ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,638, issued on July 15, was assigned to KEZAR LIFE SCIENCES INC. (South San Francisco, Calif.).
"Immunoproteasome inhibitor formulations" was invented by Evan Lewis (Pacifica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical formulations comprising KZR-616 or a salt thereof, and a sugar, wherein the formulations are lyophilized, methods of preparing said formulations, methods of treating immune-related diseases, and methods of treating inflammation."
The patent was filed on Oct. 4, 2019, under Application No. 17/281,404.
*For further information, including images, charts and tables, please visit: http://patf...